|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Interest earned on marketable securities | |||||
| Change in fair value of convertible promissory notes | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current and non- current assets | |||||
| Accounts payable and other current liabilities | |||||
| Operating lease right-of-use asset and liability, net | |||||
| Net cash used in operating activities | |||||
| Purchase of marketable securities | |||||
| Maturity of marketable securities | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Decoy’s transaction costs | |||||
| Proceeds from issuance of convertible promissory notes | |||||
| Proceeds from issuance of preferred stock | |||||
| Proceeds from exercise of pre-funded warrants | |||||
| Issuance costs | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Noncash investing and financing activities | |||||
| ASC 842 lease renewal option exercise | |||||
| Transaction costs in accounts payable and other current liabilities | |||||
| Change in accumulated other comprehensive income | |||||
| Cash paid for income taxes | |||||
| Settlement of convertible promissory notes | |||||
| Issuance of commitment shares | |||||
Loading...